相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance
Carla Nasca et al.
MOLECULAR PSYCHIATRY (2021)
Association of Insulin Resistance With Depression Severity and Remission Status Defining a Metabolic Endophenotype of Depression
Kathleen T. Watson et al.
JAMA PSYCHIATRY (2021)
Neuropathological evidence of body-first vs. brain-first Lewy body disease
Per Borghammer et al.
NEUROBIOLOGY OF DISEASE (2021)
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression
Harneek Chohan et al.
MOVEMENT DISORDERS (2021)
Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson's disease
Seong Ho Jeong et al.
BRAIN (2021)
Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer's disease
Mingcui Zheng et al.
3 BIOTECH (2021)
Effect of diabetes control status on the progression of Parkinson's disease: A prospective study
Ruwei Ou et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein
Ivan Martinez-Valbuena et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study
Kathleen T. Watson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study
Jacob Horsager et al.
BRAIN (2020)
Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease
Seok Jong Chung et al.
PARKINSONISM & RELATED DISORDERS (2019)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
Natalia de M. Lyra e Silva et al.
FRONTIERS IN PSYCHIATRY (2019)
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2019)
Age and time course of long-term motor and nonmotor complications in Parkinson disease
Stephane Prange et al.
NEUROLOGY (2019)
Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies
Ivan Martinez-Valbuena et al.
ACTA NEUROPATHOLOGICA (2018)
Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA
Katelyn Becker et al.
MOLECULAR NEUROBIOLOGY (2018)
Diabetes mellitus and Parkinson disease
Gennaro Pagano et al.
NEUROLOGY (2018)
Association between diabetes and subsequent Parkinson disease A record-linkage cohort study
Eduardo De Pablo-Fernandez et al.
NEUROLOGY (2018)
Insulin resistance, an unmasked culprit in depressive disorders: Promises for interventions
Kathleen Watson et al.
NEUROPHARMACOLOGY (2018)
Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease
Sathiya Sekar et al.
NEUROSCIENCE LETTERS (2018)
Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease
Raymond S. Schwartz et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Glitazone Use Associated With Reduced Risk of Parkinson's Disease
Brage Brakedal et al.
MOVEMENT DISORDERS (2017)
Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study
Anders Bjornestad et al.
PARKINSONISM & RELATED DISORDERS (2017)
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease
M. Petrou et al.
ACADEMIC RADIOLOGY (2016)
The Association Between Multimorbidity and Quality of Life, Health Status and Functional Disability
Joni S. Williams et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease
Istvan Horvath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Too many covariates and too few cases? - a comparative study
Qingxia Chen et al.
STATISTICS IN MEDICINE (2016)
Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study
C. D. Moulton et al.
PRIMARY CARE DIABETES (2016)
Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans
Fernando Caravaggio et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Type 2 diabetes as a protein misfolding disease
Abhisek Mukherjee et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Tracking Parkinson's: Study Design and Baseline Patient Data
Naveed Malek et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Psychiatric aspects of Parkinson's disease
Sandeep Grover et al.
JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE (2015)
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
Nicolaas I. Bohnen et al.
PARKINSONISM & RELATED DISORDERS (2014)
Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation
B. I. Perez-Revuelta et al.
CELL DEATH & DISEASE (2014)
Macro- and Microstructural Magnetic Resonance Imaging Indices Associated With Diabetes Among Community-Dwelling Older Adults
Cherie M. Falvey et al.
DIABETES CARE (2013)
Diabetes is associated with postural instability and gait difficulty in Parkinson disease
Vikas Kotagal et al.
PARKINSONISM & RELATED DISORDERS (2013)
Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
Jose A. Santiago et al.
PLOS ONE (2013)
Shared dysregulated pathways lead to Parkinson's disease and diabetes
Jose A. Santiago et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
Patrick Imfeld et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
Clinical features of Parkinson disease when onset of diabetes came first A case-control study
E. Cereda et al.
NEUROLOGY (2012)
The natural history of treated Parkinson's disease in an incident, community based cohort
Jonathan R. Evans et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Methods of Covariate Selection: Directed Acyclic Graphs and the Change-in-Estimate Procedure
Hsin-Yi Weng et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease
Daniel Weintraub et al.
MOVEMENT DISORDERS (2009)
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
S. Hoops et al.
NEUROLOGY (2009)
Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
Yaomin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation
Linda B. Moran et al.
NEUROGENETICS (2008)
Let's ask them: A national survey of definitions of quality of life and its enhancement among people aged 65 and over
A Bowling et al.
INTERNATIONAL JOURNAL OF AGING & HUMAN DEVELOPMENT (2003)
The prevalence of comorbid depression in adults with diabetes - A meta-analysis
RJ Anderson et al.
DIABETES CARE (2001)
分享论文
